Cargando…

Pregnancy of unknown location

Pregnancy of unknown location is a situation in which a positive pregnancy test occurs, but a transvaginal ultrasound does not show intrauterine or ectopic gestation. One great concern of pregnancy of unknown location is that they are cases of ectopic pregnancy whose diagnosis might be postponed. Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Pedro Paulo, Cabar, Fábio Roberto, Gomez, Úrsula Trovato, Francisco, Rossana Pulcineli Vieira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784610/
https://www.ncbi.nlm.nih.gov/pubmed/31618321
http://dx.doi.org/10.6061/clinics/2019/e1111
_version_ 1783457775087517696
author Pereira, Pedro Paulo
Cabar, Fábio Roberto
Gomez, Úrsula Trovato
Francisco, Rossana Pulcineli Vieira
author_facet Pereira, Pedro Paulo
Cabar, Fábio Roberto
Gomez, Úrsula Trovato
Francisco, Rossana Pulcineli Vieira
author_sort Pereira, Pedro Paulo
collection PubMed
description Pregnancy of unknown location is a situation in which a positive pregnancy test occurs, but a transvaginal ultrasound does not show intrauterine or ectopic gestation. One great concern of pregnancy of unknown location is that they are cases of ectopic pregnancy whose diagnosis might be postponed. Transvaginal ultrasound is able to identify an ectopic pregnancy with a sensitivity ranging from 87% to 94% and a specificity ranging from 94% to 99%. A patient with pregnancy of unknown location should be followed up until an outcome is obtained. The only valid biomarkers with clinical application and validation are serum levels of the beta fraction of hCG and progesterone. A single serum dosage of hCG is used only to determine whether the value obtained is above or below the discriminatory zone, that means the value of serum hCG above which an intrauterine gestational sac should be visible on ultrasound. Serum progesterone levels are a satisfactory marker of pregnancy viability, but they are unable to predict the location of a pregnancy of unknown location: levels below 5 ng/mL are associated with nonviable gestations, whereas levels above 20 ng/mL are correlated with viable intrauterine pregnancies. Most cases are low risk and can be monitored by expectant management with transvaginal ultrasound and serial serum hCG levels, in addition to the serum progesterone levels. To minimize diagnostic error and intervene during progressive intrauterine gestation, protocol indicates active treatment only in situations when progressive intrauterine pregnancy is excluded and a high possibility of ectopic pregnancy exists.
format Online
Article
Text
id pubmed-6784610
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Faculdade de Medicina / USP
record_format MEDLINE/PubMed
spelling pubmed-67846102019-11-13 Pregnancy of unknown location Pereira, Pedro Paulo Cabar, Fábio Roberto Gomez, Úrsula Trovato Francisco, Rossana Pulcineli Vieira Clinics (Sao Paulo) Review Article Pregnancy of unknown location is a situation in which a positive pregnancy test occurs, but a transvaginal ultrasound does not show intrauterine or ectopic gestation. One great concern of pregnancy of unknown location is that they are cases of ectopic pregnancy whose diagnosis might be postponed. Transvaginal ultrasound is able to identify an ectopic pregnancy with a sensitivity ranging from 87% to 94% and a specificity ranging from 94% to 99%. A patient with pregnancy of unknown location should be followed up until an outcome is obtained. The only valid biomarkers with clinical application and validation are serum levels of the beta fraction of hCG and progesterone. A single serum dosage of hCG is used only to determine whether the value obtained is above or below the discriminatory zone, that means the value of serum hCG above which an intrauterine gestational sac should be visible on ultrasound. Serum progesterone levels are a satisfactory marker of pregnancy viability, but they are unable to predict the location of a pregnancy of unknown location: levels below 5 ng/mL are associated with nonviable gestations, whereas levels above 20 ng/mL are correlated with viable intrauterine pregnancies. Most cases are low risk and can be monitored by expectant management with transvaginal ultrasound and serial serum hCG levels, in addition to the serum progesterone levels. To minimize diagnostic error and intervene during progressive intrauterine gestation, protocol indicates active treatment only in situations when progressive intrauterine pregnancy is excluded and a high possibility of ectopic pregnancy exists. Faculdade de Medicina / USP 2019-10-09 2019 /pmc/articles/PMC6784610/ /pubmed/31618321 http://dx.doi.org/10.6061/clinics/2019/e1111 Text en Copyright © 2019 CLINICS http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
spellingShingle Review Article
Pereira, Pedro Paulo
Cabar, Fábio Roberto
Gomez, Úrsula Trovato
Francisco, Rossana Pulcineli Vieira
Pregnancy of unknown location
title Pregnancy of unknown location
title_full Pregnancy of unknown location
title_fullStr Pregnancy of unknown location
title_full_unstemmed Pregnancy of unknown location
title_short Pregnancy of unknown location
title_sort pregnancy of unknown location
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784610/
https://www.ncbi.nlm.nih.gov/pubmed/31618321
http://dx.doi.org/10.6061/clinics/2019/e1111
work_keys_str_mv AT pereirapedropaulo pregnancyofunknownlocation
AT cabarfabioroberto pregnancyofunknownlocation
AT gomezursulatrovato pregnancyofunknownlocation
AT franciscorossanapulcinelivieira pregnancyofunknownlocation